Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.
Company profile
Ticker
ATRI
Exchange
Website
CEO
David A. Battat
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ALATENN RESOURCES INC
SEC CIK
Corporate docs
Subsidiaries
Atrion Medical Products, Inc. • Halkey-Roberts Corporation • Quest Medical, Inc. • AlaTenn Pipeline Company LLC • Atrion Leasing Company LLC ...
IRS number
630821819
ATRI stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
9 Mar 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
Atrion Reports Fourth Quarter and Full Year 2022 Results
27 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Atrion Reports Third Quarter 2022 Results
8 Nov 22
8-K
Departure of Directors or Certain Officers
6 Oct 22
8-K
Atrion Corporation Announces Cfo Succession Plan
25 Aug 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
8-K
Atrion Reports Second Quarter 2022 Results
8 Aug 22
Latest ownership filings
4
EMILE A BATTAT
21 Mar 23
4
David A Battat
21 Mar 23
4
Cindy Ferguson
10 Mar 23
4
JEFFERY STRICKLAND
7 Mar 23
4
JEFFERY STRICKLAND
7 Mar 23
3
Cindy Ferguson
6 Mar 23
SC 13G/A
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
14 Feb 23
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 23
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 23
SC 13G/A
Neuberger Berman Group LLC
10 Feb 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.73 mm | 4.73 mm | 4.73 mm | 4.73 mm | 4.73 mm | 4.73 mm |
| Cash burn (monthly) | 7.46 mm | 2.29 mm | (no burn) | (no burn) | 52.67 k | (no burn) |
| Cash used (since last report) | 22.54 mm | 6.93 mm | n/a | n/a | 159.02 k | n/a |
| Cash remaining | -17.81 mm | -2.20 mm | n/a | n/a | 4.57 mm | n/a |
| Runway (months of cash) | -2.4 | -1.0 | n/a | n/a | 86.8 | n/a |
Institutional ownership, Q4 2022
1.6% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 112 |
| Opened positions | 15 |
| Closed positions | 18 |
| Increased positions | 35 |
| Reduced positions | 38 |
| 13F shares | Current |
|---|---|
| Total value | 600.19 bn |
| Total shares | 1.13 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Neuberger Berman | 194.91 k | $109.04 bn |
| Kayne Anderson Rudnick Investment Management | 190.61 k | $106.64 bn |
| T. Rowe Price Investment Management | 115.57 k | $64.86 bn |
| BLK Blackrock | 113.36 k | $63.42 bn |
| Vanguard | 83.71 k | $46.83 bn |
| Dimensional Fund Advisors | 51.82 k | $28.99 mm |
| Renaissance Technologies | 39.01 k | $21.89 bn |
| STT State Street | 35.42 k | $19.82 bn |
| Boston Trust Walden | 30.77 k | $17.22 bn |
| Geode Capital Management | 28.44 k | $15.96 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Mar 23 | Cindy Ferguson | RSU Common stock | Grant | Acquire A | No | No | 0 | 480.08 | 0.00 | 595.02 |
| 3 Mar 23 | Strickland Jeffery | Common Stock | Payment of exercise | Dispose F | Yes | No | 628.21 | 33 | 20.73 k | 1,180 |
| 3 Mar 23 | Strickland Jeffery | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 136 | 0.00 | 1,213 |
| 3 Mar 23 | Strickland Jeffery | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 136.93 | 0.00 | 0 |
| 27 Feb 23 | Strickland Jeffery | Common Stock | Gift | Dispose G | Yes | No | 0 | 75 | 0.00 | 1,077 |
| 23 Jan 23 | Strickland Jeffery | Common Stock | Gift | Dispose G | Yes | No | 0 | 150 | 0.00 | 1,152 |
| 3 Jan 23 | Strickland Jeffery | RSU Common stock | Grant | Acquire A | No | No | 0 | 1.79 | 0.00 | 136.93 |
| 3 Jan 23 | Stupp John P JR | stock units Common shares | Grant | Acquire A | No | No | 559.45 | 35.75 | 20.00 k | 550.91 |
| 3 Jan 23 | Stupp John P JR | stock units Common shares | Grant | Acquire A | No | No | 0 | 6.79 | 0.00 | 515.16 |